Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who had surgery to remove part of their liver.
- People whose tissue samples, examined in the lab after surgery, confirmed a diagnosis of primary hepatic sarcoma (a rare type of cancer that starts in the liver).
Who may not be able to join:
- People who received any anti-cancer treatments before their surgery, such as radiofrequency ablation (a procedure using heat to destroy tumour tissue), chemotherapy delivered directly to the liver's blood supply, radiation therapy, or systemic (whole-body) drug treatments.
- People diagnosed with certain other specific types of sarcoma (confirm with trial site).
- People who had another type of cancer at the same time as their liver sarcoma diagnosis.
- People whose medical records are incomplete or who were lost to follow-up after their treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18980606725
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.